The effect of mepolizumab dosage form on treatment outcomes in severe asthma
Mepolizumab improved real-life clinical outcomes in patients with severe asthma, regardless of the dosage forms or homecare settings.
Authors
- Beata Hutyrová
- Ondřej Fibigr
- Jiří Zeman (ORCID: https://orcid.org/0000-0002-7258-9390)
- Irena Krčmová
- Sylvie Pavloková (ORCID: https://orcid.org/0000-0003-1414-2889)
- Martina Vetchá
- David Vetchý (ORCID: https://orcid.org/0000-0003-2476-9861)
- Kateřina Kubová (ORCID: https://orcid.org/0000-0002-4970-2084)
- Eva Voláková (ORCID: https://orcid.org/0000-0002-6388-8022)
- Alena Vlachová
- Constantinos Glynos
Institutions
- Charles University (CZ)
- Masaryk University (CZ)
- Jan Evangelista Purkyně University in Ústí nad Labem (CZ)
- University Hospital in Motol (CZ)
- University Hospital Olomouc (CZ)
- Athens Medical Center (GR)
- University Hospital Hradec Králové (CZ)
- Palacký University Olomouc (CZ)
- University of Hradec Králové (CZ)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-04-17
- DOI
- https://doi.org/10.3389/fmed.2025.1537074
- Citations
- 1
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.16